- Home
- ESCA vs RNA Comparison
ESCA vs RNA Comparison
Compare ESCA & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESCA | RNA |
|---|---|---|
| Founded | 1922 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.2M | 211.6M |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ESCA | RNA |
|---|---|---|
| Price | $18.82 | $13.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $69.26 |
| AVG Volume (30 Days) | 31.2K | ★ 221.8K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | ★ 6.45 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $180,541,000.00 | N/A |
| Revenue This Year | $4.15 | $88.12 |
| Revenue Next Year | N/A | $18.11 |
| P/E Ratio | $59.56 | ★ N/A |
| Revenue Growth | ★ 2.71 | N/A |
| 52 Week Low | $11.41 | $11.40 |
| 52 Week High | $21.32 | $73.06 |
Technical Indicators
Market Signals| Indicator | ESCA | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 49.04 |
| Support Level | $17.42 | $12.72 |
| Resistance Level | $18.91 | $14.05 |
| Average True Range (ATR) | 0.78 | 0.51 |
| MACD | 0.05 | 0.12 |
| Stochastic Oscillator | 68.00 | 45.63 |
Price Performance
Historical ComparisonAbout ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.
About RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.